Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
NCT Number: NCT07296575
The goal of this observational study is to evaluate the diagnostic accuracy and clinical workflow integration of an ultrasound intelligent agent (UIA) for thyroid disease management in a real-world multicenter setting. The primary research question is:
Can the UIA improve diagnostic consistency and efficiency for thyroid nodules (TI-RADS 1-5), Hashimoto's thyroiditis, and cervical lymph node metastasis compared to traditional ultrasound interpretation? Participants will include adults (18-80 years) undergoing thyroid ultrasound at 16 participating hospitals across China. Key inclusion criteria cover patients with suspected thyroid disorders requiring imaging, while exclusion criteria address poor image quality or concurrent clinical trials. Over 2,000 cases (50% thyroid nodules, 30% diffuse lesions, 12.5% non-nodular abnormalities, 7.5% special populations) will be prospectively enrolled. Data collection integrates static/dynamic ultrasound images, laboratory results, and AI-generated reports. Primary endpoints include model performance metrics (AUC, sensitivity/specificity, TI-RADS Kappa ≥0.8), workflow efficiency (report generation time ≤5 minutes), and pediatric/pregnancy-specific reference standards. Secondary analyses will assess inter-rater reliability (Cohen's Kappa) and longitudinal outcomes via 6-12-month follow-up. This study aims to establish evidence-based guidelines for AI-augmented thyroid diagnosis, particularly in underserved regions, while addressing gaps in current AI validation frameworks related to multi-modality data fusion and special population adaptability.
This study is active but is not currently recruiting participants.
All sexes
Observational
Nanchang, Jiangxi, 330006, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
no Intervention
Time frame: Within 12 months of enrollment for each patient at the time of study completion.
Diagnosing thyroid diseases using a large model in the field of ultrasound thyroid imaging, with histopathological examination results of thyroid lesions as the gold standard, to evaluate the model's sensitivity, specificity, accuracy, and area under the receiver operating characteristic curve (AUC) for diagnosing thyroid diseases.
Second Affiliated Hospital of Nanchang University
Other
A Multicenter Study on Multimodal Diagnosis and Process Optimization of Thyroid Diseases Based on Ultrasonic Intelligent Agents
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07488585
Endocrine Gland Neoplasms, Endocrine System Diseases
View Trial DetailsNCT06653907
Endocrine System Diseases, Pregnancy Outcomes
Shijiazhuang, Heibei, China
View Trial DetailsNCT04623801
Endocrine Gland Neoplasms, Endocrine System Diseases
New York, United States
View Trial DetailsNCT05733013
Endocrine Gland Neoplasms, Endocrine System Diseases
New York, United States
View Trial Details